share_log

aTyr Pharma | 8-K: aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

SEC ·  Mar 15 04:06
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.